Healthcare

Revelation Biosciences, Inc. (NASDAQ:REVB), a clinical-stage life-sciences micro-cap, was among the notable decliners of the October 16, 2026 session. The shares closed at $0.485, down 36.41% on the day, a move that pushed the stock well below the dollar mark and underscored how exposed …

Recursion Pharmaceuticals (NASDAQ:RXRX) shares closed Friday, October 16, 2026, at $3.47, down 16.71% on the day, a decline that placed the AI-driven drug-discovery company among the session’s biggest percentage losers. The move sat at the intersection of two of the day’s most powerful forces: …

GRAIL, Inc. (NASDAQ:GRAL) shares fell sharply on Friday, October 16, 2026, closing at $117.81, a decline of 13.03% on the day. The cancer-screening biotechnology company ranked among the larger single-session losers in the US market. There was no confirmed company-specific news tied to GRAIL …

Fractyl Health, Inc. (NASDAQ:GUTS), the metabolic-disease and obesity-focused biotechnology company, suffered one of the day’s most punishing declines on October 16, 2026, closing at $1.550 after falling 62.74%. A single-session loss of that size in a clinical-stage biotech is the kind of move markets …

Moleculin Biotech, Inc. (NASDAQ:MBRX) was among Friday’s steep decliners, closing at $0.280 for a loss of 24.24% on the day. The move extended the volatility that is characteristic of clinical-stage biotechnology micro-caps, a group whose share prices often swing sharply on shifts in sentiment, …

● The Health Care Select Sector SPDR Fund also reached record highs.

MDxHealth SA (NASDAQ:MDXH), the Belgium-based cancer-diagnostics company whose American depositary shares trade in the United States, was one of the most violent decliners of the October 16, 2026 session. The ADR closed at $0.207, a loss of 65.77% on the day, a move that …